Eli Lilly and Company

Eli Lilly and Company

Pharmaceutical Manufacturing

Indianapolis, Indiana 1,858,264 followers

Über uns

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Website
http://www.lilly.com/
Industrie
Pharmaceutical Manufacturing
Größe des Unternehmens
10.001+ Mitarbeiter
Hauptsitz
Indianapolis, Indiana
Typ
Öffentliches Unternehmen
Spezialitäten
Pharmaceutical Development, Pharmaceuticals, Biotech, and Biopharmaceuticals

Standorte

Employees at Eli Lilly and Company

Aktualisierungen

  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    Making the medicines that change people’s lives comes with ups and downs. But when you know the impact it could have, you can’t give up. Our team knows the responsibility they have for the people who are waiting for a breakthrough, and they’re called to deliver. The recent opening of the Lilly Seaport Innovation Center in Boston is a new home for bold scientific advancements—including genetic medicine research—to give people around the world new hope. #WeAreLilly

  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    Obesity is a chronic disease that requires management over time and may increase the risk of other serious diseases, including type 2 diabetes. We’re focused on advancing treatments that may aid long-term health outcomes and address weight-related health complications over time. Today, we shared results from a three-year study evaluating a potential treatment to reduce the risk of progression to type 2 diabetes in adults with pre-diabetes and obesity or overweight. Learn more: https://e.lilly/3yz7aWw

  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    Can you imagine a world where Alzheimer’s disease is a distant memory? We have hope that someday it will be, and recent advances could bring us closer to that goal.  Read more from Anne White on new hope for Alzheimer’s and other neurodegenerative diseases. #WeAreLilly 

    View profile for Anne White, graphic

    President, Lilly Neuroscience at Eli Lilly and Company

    As we celebrate new scientific breakthroughs in Alzheimer’s disease, I’m reminded of my mother Margaret. The heart and soul of our family, this disease robbed her of the things she loved most – cooking, music and caring for her grandkids. Nearly two decades later, the story of Alzheimer’s is being rewritten, and innovations are giving families the chance for more time together.     In an opinion editorial I penned in Fortune, I reflect on how this disease affected my family, the need for earlier detection and timely diagnosis, and what today’s developments mean for the future of treating Alzheimer’s and other neurological conditions.     Scientific breakthroughs came too late for my mom, but they are not too late for people diagnosed today. Let’s reframe how we think about Alzheimer’s, discuss the signs and symptoms, neutralize the stigma, and create a care system that delivers for all patients. Learn more: https://e.lilly/3RUbWUN        #WeAreLilly 

    • Keine alternative Textbeschreibung für dieses Bild
  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    What’s the only thing that makes rooting for Team USA better? Knowing that every medal or record you cheered for increased the amount Lilly committed to donating to a charitable organization working to improve health equity. After the close of the Olympic Games Paris 2024, 339 medals and records amounted to $1,695,000 for organizations helping advance charitable health equity efforts through our Milestones into Meaning™ donation program. But the numbers aren’t final yet! Keep watching Team USA athletes compete to win additional medals and set records to further increase Lilly’s donations during the Paralympic Games Paris 2024 and learn more about how their achievements are supporting health equity efforts here: https://e.lilly/4crFtfR #WeAreLilly

    • Keine alternative Textbeschreibung für dieses Bild
  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    Bold science happens here. Today marks the official opening of the Lilly Seaport Innovation Center (LSC), our new state-of-the-art research and development facility focused on finding solutions that can help people around the world live healthier. Tackling some of the most complex health challenges requires the right team of experts, the right technology and right environment to support smart, bold risks. LSC is focused on cutting edge science and genetic medicines to deliver for people who need it most: https://e.lilly/4dmDuL8 #WeAreLilly

    • Keine alternative Textbeschreibung für dieses Bild
  • View organization page for Eli Lilly and Company, graphic

    1,858,264 followers

    Every two years, we get to watch the world’s best take the stage. They show us what strength, grit and determination look like. They have us screaming at our tv screens and reliving the highs through clips. They’re moved by the ups and downs of this exhilarating journey and we’re right there too. Thank you to each of our Team USA athletes who allowed us to come along for the ride. Congratulations to you all! #WeAreLilly

    • Keine alternative Textbeschreibung für dieses Bild

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Eli Lilly and Company 1 total round

Letzte Runde

Post IPO debt

US$ 6.5M

Siehe mehr Informationen auf crunchbase